The Head of Global Marketing Strategy for Efdoralprin Alpha will be responsible for the successful launch and long-term success of the brand in the Rare Diseases Franchise, with a focus on alpha-1 antitrypsin deficiency (AATD). This role will act as Chief Marketing Officer of the brand and will lead a senior-level, cross-functional Global Brand Team. The scope of the role entails taking Efdoralprin Alpha through Global pre-launch, launch, and post-launch phases. Responsibilities include developing comprehensive Global pre-launch and launch plans, ensuring excellence in launch execution. This will require advanced level strategic agility, demonstrated cross-functional leadership, executive level communication, and enterprise networking skills. Global and US launch experience, as well as a background in Rare Disease and Respiratory, are critical to enable development of novel approaches to bring this best-in-class treatment to patients. Additional responsibilities include navigating the increasingly challenging access and pricing environment and shaping the regulatory approval process, all with a strong focus on compliance. This potential therapy has blockbuster commercial potential, and we are looking for an exceptional leader with a proven track record of building blockbuster brands. The position reports to the Global TA Head Rare Disease Launches and will be based in Cambridge, Massachusetts.